학술논문
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12–14-month-old children
Document Type
Article
Author
Source
In: Vaccine . (Vaccine, 27 January 2023, 41(5):1153-1160)
Subject
Language
English
ISSN
18732518
0264410X
0264410X